Posted in | News | Biofuels | Biomaterials

Cobalt Partners to Build Complete Biomass-to-Butadiene Solution

Cobalt Technologies, a leading developer of next generation bio-based chemicals, today announced a strategic relationship with two prominent Asian chemical companies for the development of a complete biomass-to-butadiene solution, to be followed by construction of a commercial-scale biorefinery in Asia.

The partners also plan to build or license additional plants to support the high growth in global butadiene demand. In support of the relationship, the partners made an equity investment in Cobalt.

A $40 billion market worldwide, butadiene is widely used in the manufacture of synthetic rubber and nylon. Butadiene is also a key ingredient in high mileage "eco-tires", a market the company expects to grow rapidly as automakers seek to meet higher fuel economy standards.

"This agreement validates Cobalt's ability to leverage its biobutanol platform into large high-value markets for downstream chemicals. With this agreement, we now have a path to fully-funded, large scale commercial projects in two of the three main geographies for bio-based projects – Asia and Brazil," said Bob Mayer , CEO of Cobalt Technologies. "We believe that our long term focus on using biomass-based feedstock, as opposed to food-based sugars, has resulted in a technology advantage and lower cost production that is attracting partners worldwide."

Under the terms of the strategic relationship, Cobalt and the partners will work together on the development of integrated technology for the conversion of biomass to butadiene. The integrated technology will form the basis for construction of a commercial-scale biomass-to-butadiene biorefinery. Work to date has demonstrated that this solution can be highly competitive with petroleum-based butadiene under current market conditions. Technology development is expected to be completed in 2014 with construction of the first plant to follow.

Source: http://www.cobalttech.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.